• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
128.53
448687.64
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.86
 

Timken India consolidated net profit declines 16.81% in the March 2026 quarter
May 19,2026
Net profit of Timken India declined 16.81% to Rs 158.31 crore in the quarter ended March 2026 as against Rs 190.31 crore during the previous quarter ended March 2025. Sales rose 14.54% to Rs 1089.83 crore in the quarter ended March 2026 as against Rs 951.46 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.23% to Rs 414.89 crore in the year ended March 2026 as against Rs 462.19 crore during the previous year ended March 2025. Sales rose 8.78% to Rs 3478.03 crore in the year ended March 2026 as against Rs 3197.20 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1089.83951.46 15 3478.033197.20 9
OPM %22.1822.51 -18.1819.12 -
PBDT241.63227.17 6 658.68657.79 0
PBT212.03206.22 3 552.63572.68 -4
NP158.31190.31 -17 414.89462.19 -10